|
시장보고서
상품코드
1911426
전신성 염증 반응 증후군 치료 시장(2026-2030년)Global Systemic Inflammatory Response Syndrome Treatment Market 2026-2030 |
||||||
※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.
세계의 전신성 염증 반응 증후군 치료 시장은 2025년부터 2030년까지 51억 1,700만 달러 증가하고, 예측 기간 동안 CAGR은 6.1%로 예측됩니다.
세계의 전신성 염증 반응 증후군 치료 시장에 대해 조사분석했으며, 시장 규모와 예측, 동향, 성장요인, 과제, 약 25개 벤더 분석 등의 정보를 전해드립니다.
본 보고서는 현재 시장 상황, 최신 동향 및 촉진요인, 시장 환경 전반에 대한 최신 분석을 제공합니다. 이 시장은 전 세계적으로 패혈증 및 관련 염증성 질환의 발생률 증가, 진단 기술 및 바이오마커 발견의 획기적인 발전, 탄탄한 R&D 파이프라인, 새로운 치료법에 대한 투자 증가에 힘입어 성장세를 보이고 있습니다.
이번 조사는 업계 주요 관계자들의 정보를 포함한 1차 정보와 2차 정보의 객관적인 조합을 통해 이루어졌습니다. 이 보고서에는 주요 기업 분석과 함께 종합적인 시장 규모 데이터, 지역별 분석과 함께 부문 및 공급업체 현황이 포함되어 있습니다. 보고서에는 과거 데이터와 예측 데이터가 수록되어 있습니다.
| 시장 범위 | |
|---|---|
| 기준 연도 | 2026년 |
| 대상 기간 | 2030년 |
| 예측 기간 | 2026-2030년 |
| 성장 모멘텀 | 가속 |
| 전년비 2026년 | 5.7% |
| CAGR | 6.1% |
| 증가액 | 51억 1,700만 달러 |
이 보고서는 정밀의료와 바이오마커에 기반한 계층화가 부상하고 있는 것이 향후 몇 년 동안 세계 전신성 염증 반응 증후군 치료 시장 성장을 견인할 주요 요인 중 하나로 꼽았습니다. 또한, 첨단 면역 조절 요법과 사이토카인 표적 치료제의 등장, 그리고 인공지능과 디지털 헬스케어의 임상 워크플로우 통합은 시장에서 상당한 수요를 창출할 것으로 예상됩니다.
목차
제1장 주요 요약
제2장 Technavio 분석
- 가격 반응성·수명주기·고객 구입 바스켓·채용률·구입 기준 분석
- 인풋의 중요성과 차별화 요인
- 혼란 요인
- 성장 촉진요인과 과제의 영향
제3장 시장 구도
- 시장 생태계
- 시장 특징
- 밸류체인 분석
제4장 시장 규모
- 시장 정의
- 시장 부문 분석
- 시장 규모, 2025년
- 시장 전망, 2025-2030년
제5장 시장 규모 실적
- 전신성 염증 반응 증후군 치료 시장, 2020-2024년
- 투여 경로별 부문 분석, 2020-2024년
- 유통 채널별 부문 분석, 2020-2024년
- 최종사용자별 부문 분석, 2020-2024년
- 지역별 부문 분석, 2020-2024년
- 국가별 부문 분석, 2020-2024년
제6장 정성 분석
- 전신성 염증 반응 증후군 치료 시장에 대한 AI의 영향
제7장 Five Forces 분석
- Five Forces 요약
- 구매자의 교섭력
- 공급 기업의 교섭력
- 신규 참여업체의 위협
- 대체품의 위협
- 경쟁의 위협
- 시장 상황
제8장 시장 세분화 : 투여 경로별
- 비교 : 투여 경로별
- 정맥내 투여
- 경구
- 시장 기회 : 투여 경로별
제9장 시장 세분화 : 유통 채널별
- 비교 : 유통 채널별
- 오프라인
- 온라인
- 시장 기회 : 유통 채널별
제10장 시장 세분화 : 최종사용자별
- 비교 : 최종사용자별
- 병원
- 진료소
- 기타
- 시장 기회 : 최종사용자별
제11장 고객 상황
제12장 지역별 상황
- 지역별 세분화
- 지역별 비교
- 북미
- 미국
- 캐나다
- 멕시코
- 유럽
- 독일
- 영국
- 프랑스
- 이탈리아
- 네덜란드
- 스페인
- 러시아
- 아시아
- 중국
- 인도
- 일본
- 한국
- 인도네시아
- 태국
- 싱가포르
- 세계 기타 지역
- 브라질
- 호주
- 남아프리카공화국
- UAE
- 사우디아라비아
- 튀르키예
- 시장 기회 : 지역별
제13장 촉진요인, 과제, 기회
- 시장 성장 촉진요인
- 시장 과제
- 성장 촉진요인과 과제의 영향
- 시장 기회
제14장 경쟁 구도
- 개요
- 경쟁 구도
- 혼란 상황
- 업계 리스크
제15장 경쟁 분석
- 기업 개요
- 기업 순위 지표
- 기업의 시장 포지셔닝
- AstraZeneca Plc
- B.Braun SE
- Baxter International Inc.
- BioMerieux SA
- Edwards Lifesciences Corp.
- Eli Lilly and Co.
- F. Hoffmann La Roche Ltd.
- Fresenius Kabi AG
- GlaxoSmithKline Plc
- Johnson and Johnson Services
- Medtronic Plc
- Merck and Co. Inc.
- Novartis AG
- Pfizer Inc.
- Sanofi SA
제16장 부록
KSMThe global systemic inflammatory response syndrome treatment market is forecasted to grow by USD 5117.0 mn during 2025-2030, accelerating at a CAGR of 6.1% during the forecast period. The report on the global systemic inflammatory response syndrome treatment market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increasing global incidence of sepsis and related inflammatory conditions, significant advancements in diagnostic technologies and biomarker discovery, robust research and development pipeline and increased investment in novel therapeutics.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.
| Market Scope | |
|---|---|
| Base Year | 2026 |
| End Year | 2030 |
| Series Year | 2026-2030 |
| Growth Momentum | Accelerate |
| YOY 2026 | 5.7% |
| CAGR | 6.1% |
| Incremental Value | $5117.0 mn |
Technavio's global systemic inflammatory response syndrome treatment market is segmented as below:
By Route Of Administration
- Intravenous
- Oral
By Distribution Channel
- Offline
- Online
By End-User
- Hospitals
- Clinics
- Others
Geography
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Italy
- The Netherlands
- Spain
- Russia
- Asia
- Rest of World (ROW)
- Rest of World (ROW)
This study identifies the ascendancy of precision medicine and biomarker-driven stratification as one of the prime reasons driving the global systemic inflammatory response syndrome treatment market growth during the next few years. Also, emergence of advanced immunomodulatory and cytokine-targeted therapeutics and integration of artificial intelligence and digital health in clinical workflows will lead to sizable demand in the market.
The report on the global systemic inflammatory response syndrome treatment market covers the following areas:
- Global systemic inflammatory response syndrome treatment market sizing
- Global systemic inflammatory response syndrome treatment market forecast
- Global systemic inflammatory response syndrome treatment market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading global systemic inflammatory response syndrome treatment market vendors that include AbbVie Inc., AstraZeneca Plc, B.Braun SE, Baxter International Inc., Becton Dickinson and Co., BioMerieux SA, Dragerwerk AG and Co. KGaA, Edwards Lifesciences Corp., Eli Lilly and Co., F. Hoffmann La Roche Ltd., Fresenius Kabi AG, Getinge AB, GlaxoSmithKline Plc, Johnson and Johnson Services, Medtronic Plc, Merck and Co. Inc., Novartis AG, Pfizer Inc., Sanofi SA. Also, the global systemic inflammatory response syndrome treatment market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.
Table of Contents
1 Executive Summary
- 1.1 Market overview
- Executive Summary - Chart on Market Overview
- Executive Summary - Data Table on Market Overview
- Executive Summary - Chart on Global Market Characteristics
- Executive Summary - Chart on Market by Geography
- Executive Summary - Chart on Market Segmentation by Route of Administration
- Executive Summary - Chart on Market Segmentation by Distribution Channel
- Executive Summary - Chart on Market Segmentation by End-user
- Executive Summary - Chart on Incremental Growth
- Executive Summary - Data Table on Incremental Growth
- Executive Summary - Chart on Company Market Positioning
2 Technavio Analysis
- 2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- 2.2 Criticality of inputs and Factors of differentiation
- Chart on Overview on criticality of inputs and factors of differentiation
- 2.3 Factors of disruption
- Chart on Overview on factors of disruption
- 2.4 Impact of drivers and challenges
- Chart on Impact of drivers and challenges in 2025 and 2030
3 Market Landscape
- 3.1 Market ecosystem
- Chart on Parent Market
- Data Table on - Parent Market
- 3.2 Market characteristics
- Chart on Market characteristics analysis
- 3.3 Value chain analysis
- Chart on Value chain analysis
4 Market Sizing
- 4.1 Market definition
- Data Table on Offerings of companies included in the market definition
- 4.2 Market segment analysis
- Market segments
- 4.3 Market size 2025
- 4.4 Market outlook: Forecast for 2025-2030
- Chart on Global - Market size and forecast 2025-2030 ($ million)
- Data Table on Global - Market size and forecast 2025-2030 ($ million)
- Chart on Global Market: Year-over-year growth 2025-2030 (%)
- Data Table on Global Market: Year-over-year growth 2025-2030 (%)
5 Historic Market Size
- 5.1 Global Systemic Inflammatory Response Syndrome Treatment Market 2020 - 2024
- Historic Market Size - Data Table on Global Systemic Inflammatory Response Syndrome Treatment Market 2020 - 2024 ($ million)
- 5.2 Route of Administration segment analysis 2020 - 2024
- Historic Market Size - Route of Administration Segment 2020 - 2024 ($ million)
- 5.3 Distribution Channel segment analysis 2020 - 2024
- Historic Market Size - Distribution Channel Segment 2020 - 2024 ($ million)
- 5.4 End-user segment analysis 2020 - 2024
- Historic Market Size - End-user Segment 2020 - 2024 ($ million)
- 5.5 Geography segment analysis 2020 - 2024
- Historic Market Size - Geography Segment 2020 - 2024 ($ million)
- 5.6 Country segment analysis 2020 - 2024
- Historic Market Size - Country Segment 2020 - 2024 ($ million)
6 Qualitative Analysis
- 6.1 Impact of AI on the Global Systemic Inflammatory Response Syndrome Treatment Market
7 Five Forces Analysis
- 7.1 Five forces summary
- Five forces analysis - Comparison between 2025 and 2030
- 7.2 Bargaining power of buyers
- Bargaining power of buyers - Impact of key factors 2025 and 2030
- 7.3 Bargaining power of suppliers
- Bargaining power of suppliers - Impact of key factors in 2025 and 2030
- 7.4 Threat of new entrants
- Threat of new entrants - Impact of key factors in 2025 and 2030
- 7.5 Threat of substitutes
- Threat of substitutes - Impact of key factors in 2025 and 2030
- 7.6 Threat of rivalry
- Threat of rivalry - Impact of key factors in 2025 and 2030
- 7.7 Market condition
- Chart on Market condition - Five forces 2025 and 2030
8 Market Segmentation by Route of Administration
- 8.1 Market segments
- Chart on Route of Administration - Market share 2025-2030 (%)
- Data Table on Route of Administration - Market share 2025-2030 (%)
- 8.2 Comparison by Route of Administration
- Chart on Comparison by Route of Administration
- Data Table on Comparison by Route of Administration
- 8.3 Intravenous - Market size and forecast 2025-2030
- Chart on Intravenous - Market size and forecast 2025-2030 ($ million)
- Data Table on Intravenous - Market size and forecast 2025-2030 ($ million)
- Chart on Intravenous - Year-over-year growth 2025-2030 (%)
- Data Table on Intravenous - Year-over-year growth 2025-2030 (%)
- 8.4 Oral - Market size and forecast 2025-2030
- Chart on Oral - Market size and forecast 2025-2030 ($ million)
- Data Table on Oral - Market size and forecast 2025-2030 ($ million)
- Chart on Oral - Year-over-year growth 2025-2030 (%)
- Data Table on Oral - Year-over-year growth 2025-2030 (%)
- 8.5 Market opportunity by Route of Administration
- Market opportunity by Route of Administration ($ million)
- Data Table on Market opportunity by Route of Administration ($ million)
9 Market Segmentation by Distribution Channel
- 9.1 Market segments
- Chart on Distribution Channel - Market share 2025-2030 (%)
- Data Table on Distribution Channel - Market share 2025-2030 (%)
- 9.2 Comparison by Distribution Channel
- Chart on Comparison by Distribution Channel
- Data Table on Comparison by Distribution Channel
- 9.3 Offline - Market size and forecast 2025-2030
- Chart on Offline - Market size and forecast 2025-2030 ($ million)
- Data Table on Offline - Market size and forecast 2025-2030 ($ million)
- Chart on Offline - Year-over-year growth 2025-2030 (%)
- Data Table on Offline - Year-over-year growth 2025-2030 (%)
- 9.4 Online - Market size and forecast 2025-2030
- Chart on Online - Market size and forecast 2025-2030 ($ million)
- Data Table on Online - Market size and forecast 2025-2030 ($ million)
- Chart on Online - Year-over-year growth 2025-2030 (%)
- Data Table on Online - Year-over-year growth 2025-2030 (%)
- 9.5 Market opportunity by Distribution Channel
- Market opportunity by Distribution Channel ($ million)
- Data Table on Market opportunity by Distribution Channel ($ million)
10 Market Segmentation by End-user
- 10.1 Market segments
- Chart on End-user - Market share 2025-2030 (%)
- Data Table on End-user - Market share 2025-2030 (%)
- 10.2 Comparison by End-user
- Chart on Comparison by End-user
- Data Table on Comparison by End-user
- 10.3 Hospitals - Market size and forecast 2025-2030
- Chart on Hospitals - Market size and forecast 2025-2030 ($ million)
- Data Table on Hospitals - Market size and forecast 2025-2030 ($ million)
- Chart on Hospitals - Year-over-year growth 2025-2030 (%)
- Data Table on Hospitals - Year-over-year growth 2025-2030 (%)
- 10.4 Clinics - Market size and forecast 2025-2030
- Chart on Clinics - Market size and forecast 2025-2030 ($ million)
- Data Table on Clinics - Market size and forecast 2025-2030 ($ million)
- Chart on Clinics - Year-over-year growth 2025-2030 (%)
- Data Table on Clinics - Year-over-year growth 2025-2030 (%)
- 10.5 Others - Market size and forecast 2025-2030
- Chart on Others - Market size and forecast 2025-2030 ($ million)
- Data Table on Others - Market size and forecast 2025-2030 ($ million)
- Chart on Others - Year-over-year growth 2025-2030 (%)
- Data Table on Others - Year-over-year growth 2025-2030 (%)
- 10.6 Market opportunity by End-user
- Market opportunity by End-user ($ million)
- Data Table on Market opportunity by End-user ($ million)
11 Customer Landscape
- 11.1 Customer landscape overview
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
12 Geographic Landscape
- 12.1 Geographic segmentation
- Chart on Market share by geography 2025-2030 (%)
- Data Table on Market share by geography 2025-2030 (%)
- 12.2 Geographic comparison
- Chart on Geographic comparison
- Data Table on Geographic comparison
- 12.3 North America - Market size and forecast 2025-2030
- Chart on North America - Market size and forecast 2025-2030 ($ million)
- Data Table on North America - Market size and forecast 2025-2030 ($ million)
- Chart on North America - Year-over-year growth 2025-2030 (%)
- Data Table on North America - Year-over-year growth 2025-2030 (%)
- Chart on Regional Comparison - North America
- Data Table on Regional Comparison - North America
- 12.3.1 US - Market size and forecast 2025-2030
- Chart on US - Market size and forecast 2025-2030 ($ million)
- Data Table on US - Market size and forecast 2025-2030 ($ million)
- Chart on US - Year-over-year growth 2025-2030 (%)
- Data Table on US - Year-over-year growth 2025-2030 (%)
- 12.3.2 Canada - Market size and forecast 2025-2030
- Chart on Canada - Market size and forecast 2025-2030 ($ million)
- Data Table on Canada - Market size and forecast 2025-2030 ($ million)
- Chart on Canada - Year-over-year growth 2025-2030 (%)
- Data Table on Canada - Year-over-year growth 2025-2030 (%)
- 12.3.3 Mexico - Market size and forecast 2025-2030
- Chart on Mexico - Market size and forecast 2025-2030 ($ million)
- Data Table on Mexico - Market size and forecast 2025-2030 ($ million)
- Chart on Mexico - Year-over-year growth 2025-2030 (%)
- Data Table on Mexico - Year-over-year growth 2025-2030 (%)
- 12.4 Europe - Market size and forecast 2025-2030
- Chart on Europe - Market size and forecast 2025-2030 ($ million)
- Data Table on Europe - Market size and forecast 2025-2030 ($ million)
- Chart on Europe - Year-over-year growth 2025-2030 (%)
- Data Table on Europe - Year-over-year growth 2025-2030 (%)
- Chart on Regional Comparison - Europe
- Data Table on Regional Comparison - Europe
- 12.4.1 Germany - Market size and forecast 2025-2030
- Chart on Germany - Market size and forecast 2025-2030 ($ million)
- Data Table on Germany - Market size and forecast 2025-2030 ($ million)
- Chart on Germany - Year-over-year growth 2025-2030 (%)
- Data Table on Germany - Year-over-year growth 2025-2030 (%)
- 12.4.2 UK - Market size and forecast 2025-2030
- Chart on UK - Market size and forecast 2025-2030 ($ million)
- Data Table on UK - Market size and forecast 2025-2030 ($ million)
- Chart on UK - Year-over-year growth 2025-2030 (%)
- Data Table on UK - Year-over-year growth 2025-2030 (%)
- 12.4.3 France - Market size and forecast 2025-2030
- Chart on France - Market size and forecast 2025-2030 ($ million)
- Data Table on France - Market size and forecast 2025-2030 ($ million)
- Chart on France - Year-over-year growth 2025-2030 (%)
- Data Table on France - Year-over-year growth 2025-2030 (%)
- 12.4.4 Italy - Market size and forecast 2025-2030
- Chart on Italy - Market size and forecast 2025-2030 ($ million)
- Data Table on Italy - Market size and forecast 2025-2030 ($ million)
- Chart on Italy - Year-over-year growth 2025-2030 (%)
- Data Table on Italy - Year-over-year growth 2025-2030 (%)
- 12.4.5 The Netherlands - Market size and forecast 2025-2030
- Chart on The Netherlands - Market size and forecast 2025-2030 ($ million)
- Data Table on The Netherlands - Market size and forecast 2025-2030 ($ million)
- Chart on The Netherlands - Year-over-year growth 2025-2030 (%)
- Data Table on The Netherlands - Year-over-year growth 2025-2030 (%)
- 12.4.6 Spain - Market size and forecast 2025-2030
- Chart on Spain - Market size and forecast 2025-2030 ($ million)
- Data Table on Spain - Market size and forecast 2025-2030 ($ million)
- Chart on Spain - Year-over-year growth 2025-2030 (%)
- Data Table on Spain - Year-over-year growth 2025-2030 (%)
- 12.4.7 Russia - Market size and forecast 2025-2030
- Chart on Russia - Market size and forecast 2025-2030 ($ million)
- Data Table on Russia - Market size and forecast 2025-2030 ($ million)
- Chart on Russia - Year-over-year growth 2025-2030 (%)
- Data Table on Russia - Year-over-year growth 2025-2030 (%)
- 12.5 Asia - Market size and forecast 2025-2030
- Chart on Asia - Market size and forecast 2025-2030 ($ million)
- Data Table on Asia - Market size and forecast 2025-2030 ($ million)
- Chart on Asia - Year-over-year growth 2025-2030 (%)
- Data Table on Asia - Year-over-year growth 2025-2030 (%)
- Chart on Regional Comparison - Asia
- Data Table on Regional Comparison - Asia
- 12.5.1 China - Market size and forecast 2025-2030
- Chart on China - Market size and forecast 2025-2030 ($ million)
- Data Table on China - Market size and forecast 2025-2030 ($ million)
- Chart on China - Year-over-year growth 2025-2030 (%)
- Data Table on China - Year-over-year growth 2025-2030 (%)
- 12.5.2 India - Market size and forecast 2025-2030
- Chart on India - Market size and forecast 2025-2030 ($ million)
- Data Table on India - Market size and forecast 2025-2030 ($ million)
- Chart on India - Year-over-year growth 2025-2030 (%)
- Data Table on India - Year-over-year growth 2025-2030 (%)
- 12.5.3 Japan - Market size and forecast 2025-2030
- Chart on Japan - Market size and forecast 2025-2030 ($ million)
- Data Table on Japan - Market size and forecast 2025-2030 ($ million)
- Chart on Japan - Year-over-year growth 2025-2030 (%)
- Data Table on Japan - Year-over-year growth 2025-2030 (%)
- 12.5.4 South Korea - Market size and forecast 2025-2030
- Chart on South Korea - Market size and forecast 2025-2030 ($ million)
- Data Table on South Korea - Market size and forecast 2025-2030 ($ million)
- Chart on South Korea - Year-over-year growth 2025-2030 (%)
- Data Table on South Korea - Year-over-year growth 2025-2030 (%)
- 12.5.5 Indonesia - Market size and forecast 2025-2030
- Chart on Indonesia - Market size and forecast 2025-2030 ($ million)
- Data Table on Indonesia - Market size and forecast 2025-2030 ($ million)
- Chart on Indonesia - Year-over-year growth 2025-2030 (%)
- Data Table on Indonesia - Year-over-year growth 2025-2030 (%)
- 12.5.6 Thailand - Market size and forecast 2025-2030
- Chart on Thailand - Market size and forecast 2025-2030 ($ million)
- Data Table on Thailand - Market size and forecast 2025-2030 ($ million)
- Chart on Thailand - Year-over-year growth 2025-2030 (%)
- Data Table on Thailand - Year-over-year growth 2025-2030 (%)
- 12.5.7 Singapore - Market size and forecast 2025-2030
- Chart on Singapore - Market size and forecast 2025-2030 ($ million)
- Data Table on Singapore - Market size and forecast 2025-2030 ($ million)
- Chart on Singapore - Year-over-year growth 2025-2030 (%)
- Data Table on Singapore - Year-over-year growth 2025-2030 (%)
- 12.6 Rest of World (ROW) - Market size and forecast 2025-2030
- Chart on Rest of World (ROW) - Market size and forecast 2025-2030 ($ million)
- Data Table on Rest of World (ROW) - Market size and forecast 2025-2030 ($ million)
- Chart on Rest of World (ROW) - Year-over-year growth 2025-2030 (%)
- Data Table on Rest of World (ROW) - Year-over-year growth 2025-2030 (%)
- Chart on Regional Comparison - Rest of World (ROW)
- Data Table on Regional Comparison - Rest of World (ROW)
- 12.6.1 Brazil - Market size and forecast 2025-2030
- Chart on Brazil - Market size and forecast 2025-2030 ($ million)
- Data Table on Brazil - Market size and forecast 2025-2030 ($ million)
- Chart on Brazil - Year-over-year growth 2025-2030 (%)
- Data Table on Brazil - Year-over-year growth 2025-2030 (%)
- 12.6.2 Australia - Market size and forecast 2025-2030
- Chart on Australia - Market size and forecast 2025-2030 ($ million)
- Data Table on Australia - Market size and forecast 2025-2030 ($ million)
- Chart on Australia - Year-over-year growth 2025-2030 (%)
- Data Table on Australia - Year-over-year growth 2025-2030 (%)
- 12.6.3 South Africa - Market size and forecast 2025-2030
- Chart on South Africa - Market size and forecast 2025-2030 ($ million)
- Data Table on South Africa - Market size and forecast 2025-2030 ($ million)
- Chart on South Africa - Year-over-year growth 2025-2030 (%)
- Data Table on South Africa - Year-over-year growth 2025-2030 (%)
- 12.6.4 UAE - Market size and forecast 2025-2030
- Chart on UAE - Market size and forecast 2025-2030 ($ million)
- Data Table on UAE - Market size and forecast 2025-2030 ($ million)
- Chart on UAE - Year-over-year growth 2025-2030 (%)
- Data Table on UAE - Year-over-year growth 2025-2030 (%)
- 12.6.5 Saudi Arabia - Market size and forecast 2025-2030
- Chart on Saudi Arabia - Market size and forecast 2025-2030 ($ million)
- Data Table on Saudi Arabia - Market size and forecast 2025-2030 ($ million)
- Chart on Saudi Arabia - Year-over-year growth 2025-2030 (%)
- Data Table on Saudi Arabia - Year-over-year growth 2025-2030 (%)
- 12.6.6 Turkey - Market size and forecast 2025-2030
- Chart on Turkey - Market size and forecast 2025-2030 ($ million)
- Data Table on Turkey - Market size and forecast 2025-2030 ($ million)
- Chart on Turkey - Year-over-year growth 2025-2030 (%)
- Data Table on Turkey - Year-over-year growth 2025-2030 (%)
- 12.7 Market opportunity by geography
- Market opportunity by geography ($ million)
- Data Tables on Market opportunity by geography ($ million)
13 Drivers, Challenges, and Opportunity
- 13.1 Market drivers
- Increasing global incidence of sepsis and related inflammatory conditions
- Significant advancements in diagnostic technologies and biomarker discovery
- Robust research and development pipeline and increased investment in novel therapeutics
- 13.2 Market challenges
- High rate of clinical trial failures due to patient heterogeneity
- Diagnostic ambiguity and absence of gold standard test
- Stringent regulatory hurdles and economic barriers to market access
- 13.3 Impact of drivers and challenges
- Impact of drivers and challenges in 2025 and 2030
- 13.4 Market opportunities
- Ascendancy of precision medicine and biomarker-driven stratification
- Emergence of advanced immunomodulatory and cytokine-targeted therapeutics
- Integration of artificial intelligence and digital health in clinical workflows
14 Competitive Landscape
- 14.1 Overview
- 14.2 Competitive Landscape
- Overview on criticality of inputs and factors of differentiation
- 14.3 Landscape disruption
- Overview on factors of disruption
- 14.4 Industry risks
- Impact of key risks on business
15 Competitive Analysis
- 15.1 Companies profiled
- Companies covered
- 15.2 Company ranking index
- Company ranking index
- 15.3 Market positioning of companies
- Matrix on companies position and classification
- 15.4 AstraZeneca Plc
- AstraZeneca Plc - Overview
- AstraZeneca Plc - Product / Service
- AstraZeneca Plc - Key news
- AstraZeneca Plc - Key offerings
- SWOT
- 15.5 B.Braun SE
- B.Braun SE - Overview
- B.Braun SE - Product / Service
- B.Braun SE - Key news
- B.Braun SE - Key offerings
- SWOT
- 15.6 Baxter International Inc.
- Baxter International Inc. - Overview
- Baxter International Inc. - Business segments
- Baxter International Inc. - Key news
- Baxter International Inc. - Key offerings
- Baxter International Inc. - Segment focus
- SWOT
- 15.7 BioMerieux SA
- BioMerieux SA - Overview
- BioMerieux SA - Business segments
- BioMerieux SA - Key news
- BioMerieux SA - Key offerings
- BioMerieux SA - Segment focus
- SWOT
- 15.8 Edwards Lifesciences Corp.
- Edwards Lifesciences Corp. - Overview
- Edwards Lifesciences Corp. - Business segments
- Edwards Lifesciences Corp. - Key news
- Edwards Lifesciences Corp. - Key offerings
- Edwards Lifesciences Corp. - Segment focus
- SWOT
- 15.9 Eli Lilly and Co.
- Eli Lilly and Co. - Overview
- Eli Lilly and Co. - Product / Service
- Eli Lilly and Co. - Key offerings
- SWOT
- 15.10 F. Hoffmann La Roche Ltd.
- F. Hoffmann La Roche Ltd. - Overview
- F. Hoffmann La Roche Ltd. - Business segments
- F. Hoffmann La Roche Ltd. - Key news
- F. Hoffmann La Roche Ltd. - Key offerings
- F. Hoffmann La Roche Ltd. - Segment focus
- SWOT
- 15.11 Fresenius Kabi AG
- Fresenius Kabi AG - Overview
- Fresenius Kabi AG - Product / Service
- Fresenius Kabi AG - Key offerings
- SWOT
- 15.12 GlaxoSmithKline Plc
- GlaxoSmithKline Plc - Overview
- GlaxoSmithKline Plc - Business segments
- GlaxoSmithKline Plc - Key news
- GlaxoSmithKline Plc - Key offerings
- GlaxoSmithKline Plc - Segment focus
- SWOT
- 15.13 Johnson and Johnson Services
- Johnson and Johnson Services - Overview
- Johnson and Johnson Services - Business segments
- Johnson and Johnson Services - Key news
- Johnson and Johnson Services - Key offerings
- Johnson and Johnson Services - Segment focus
- SWOT
- 15.14 Medtronic Plc
- Medtronic Plc - Overview
- Medtronic Plc - Business segments
- Medtronic Plc - Key news
- Medtronic Plc - Key offerings
- Medtronic Plc - Segment focus
- SWOT
- 15.15 Merck and Co. Inc.
- Merck and Co. Inc. - Overview
- Merck and Co. Inc. - Business segments
- Merck and Co. Inc. - Key news
- Merck and Co. Inc. - Key offerings
- Merck and Co. Inc. - Segment focus
- SWOT
- 15.16 Novartis AG
- Novartis AG - Overview
- Novartis AG - Business segments
- Novartis AG - Key news
- Novartis AG - Key offerings
- Novartis AG - Segment focus
- SWOT
- 15.17 Pfizer Inc.
- Pfizer Inc. - Overview
- Pfizer Inc. - Product / Service
- Pfizer Inc. - Key news
- Pfizer Inc. - Key offerings
- SWOT
- 15.18 Sanofi SA
- Sanofi SA - Overview
- Sanofi SA - Business segments
- Sanofi SA - Key news
- Sanofi SA - Key offerings
- Sanofi SA - Segment focus
- SWOT
16 Appendix
- 16.1 Scope of the report
- Market definition
- Objectives
- Notes and caveats
- 16.2 Inclusions and exclusions checklist
- Inclusions checklist
- Exclusions checklist
- 16.3 Currency conversion rates for US$
- Currency conversion rates for US$
- 16.4 Research methodology
- Research methodology
- 16.5 Data procurement
- Information sources
- 16.6 Data validation
- Data validation
- 16.7 Validation techniques employed for market sizing
- Validation techniques employed for market sizing
- 16.8 Data synthesis
- Data synthesis
- 16.9 360 degree market analysis
- 360 degree market analysis
- 16.10 List of abbreviations
- List of abbreviations
샘플 요청 목록